Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darifenacin and Physiotherapy for Overactive Bladder
NCT02143570Phase 3Completed
- Sponsor
- Universidad de Valparaíso
- Start
- May 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of darifenacin in overactive bladder (OAB), sponsored by Universidad de Valparaíso. Started May 2014; status: completed.
02
Drugs
darifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT02143570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02143570.